Company profile: Biozol
1.1 - Company Overview
Company description
- Provider of products for immunology, cell biology, molecular biology, biochemistry, and human and veterinary diagnostics, including antibodies and recombinant proteins; high-purity biochemical solutions; validated antibodies for pathology; immunohistochemistry reagents; molecular biology tools such as purification columns and vector systems; and laboratory accessories for chromatography and spectroscopy.
Products and services
- Recombinant Antibodies and Proteins: Delivers reproducible recombinant antibodies and proteins engineered for consistent, safe research use, ensuring reliable experimental outcomes across immunology, cell biology, molecular biology, and biochemistry
- Dianova - Antibodies for Pathology: Supplies validated human pathology antibodies with access to a portal for secondary antibodies, supporting precise diagnostic immunostaining and marker detection in clinical workflows
- MoBiTec - Molecular Biology Products: Offers vector-based protein expression systems and purification columns for molecular biology, enabling protein expression workflows and downstream protein purification for laboratory research
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biozol
Knittel Gläser
HQ: Germany
Website
- Description: Provider of glass processing products, including slide, starfrost, and coverslip items.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Knittel Gläser company profile →
FFEI
HQ: United Kingdom
Website
- Description: Provider of digital imaging solutions, industrial digital inkjet systems, and digital life science technology, with many years of experience in technical integration and engineering projects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FFEI company profile →
Dominique Dutscher
HQ: France
Website
- Description: Provider of consumables and laboratory equipment for research, biotechnologies and health. Offers products for genetics, cell culture, molecular biology, immunology, genomics and proteomics; supplies life sciences, agri-food and industrial labs. Portfolio includes GoGreen eco-responsible range, antibodies via Ozyme, and ClearLine quantitative cellulose filter papers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dominique Dutscher company profile →
ClorDiSys Solutions
HQ: United States
Website
- Description: Provider of complete turnkey microbial decontamination services for all types of facilities and applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClorDiSys Solutions company profile →
West Pharmaceutical
HQ: United States
Website
- Description: Provider of technologically advanced containment and delivery systems for injectable medicines, offering the Envision Verification Process automated vision inspection to detect defects in pharmaceutical packaging components during fill-finish operations, Daikyo Crystal Zenith® vials made from cyclic olefin polymer for advanced therapeutics with integrity at ultra-cold temperatures, and primary packaging analytical services for compatibility and regulatory compliance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full West Pharmaceutical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biozol
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biozol
2.2 - Growth funds investing in similar companies to Biozol
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biozol
4.2 - Public trading comparable groups for Biozol
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →